Zyryanov S.K. - list of publications

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House. Vol. 10. 2018. P. 75-80

PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION

Article

Asetskaya I.L., Zyryanov S.K., Kolbin A.S., Belousov D.Yu.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 53-72

GCP INSPECTION BY ROSZDRAVNADZOR

Article

Belousov D.Yu., Zyryanov S.K., Kolbin A.S., Karpenko L.I., Rogov E.S.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 66-76

PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA

Article

Zyryanov S.K., Zatolochina K.E.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 51-57

PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER

Article

Fedyayev D.V., Zyryanov S.K.

Медицинские технологии. Оценка и выбор. Фонд развития социальной политики и здравоохранения Гелиос. 2018. P. 68-84

THE MONITORING OF DRUG USE SAFETY IN THE MULTISPECIALITY HOSPITAL

Article

Zyryanov S.K., Ivzhits M.A., Ivanov D.A.

Хирург. 2018. P. 73-79

IN VITRO EQUIVALENCE EVALUATION OF BETAHISTINE GENERIC MEDICINAL PRODUCTS AS A TOOL POTENTIALLY DETERMINING THE EFFICACY OF PHARMACOTHERAPY [OTSENKA ÉKVIVALENTNOSTI IN VITRO VOSPROIZVEDENNYKH PREPARATOV BETAGISTINA KAK INSTRUMENTA, POTENTSIAL'NO OPREDELIAIUSHCHEGO ÉFFEKTIVNOST' FARMAKOTERAPII]

Article

Zyryanov S.K., Butranova O.I., Ramenskaya G.V., Gildeeva G.N., Shohin I.E.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Vol. 118. 2018. P. 43-48

SELECTION OF MODERN P2Y12 INHIBITOR AS A PART OF DUAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON PRASUGREL

Article

Zyryanov S.K., Baibulatova E.A.

Лечебное дело. 2018. P. 50-61

EXTRACELLULAR DNA AND PLASMA NUCLEASE ACTIVITY EFFECT ON THE COURSE OF THE MICROBIAL INFLAMMATORY PROCESS IN THE RESPIRATORY TRACT IN CYSTIC FIBROSIS

Article

Kondratieva E.I., Kondakova Yu.A., Kostyuk S.V., Ershova E.V., Zyryanov S.K., Melyanovskaya Yu.L., Voronkova A.Yu., Sherman V.D., Shadrina V.V.

Journal of Bioinformatics and Genomics. Общество с ограниченной ответственностью «Цифра». 2018. 2 p.

PHARMACOEPIDEMIOLOGY OF ANTIBACTERIAL DRUGS FOR PRETERM INFANTS

Article

Dyrina K.S., Uvarova E.S., Kutsaya K.O., Zyryanov S.K., Zyryanov S.K.

Клинические и теоретические аспекты современной медицины. Российский университет дружбы народов (РУДН). 2018. 69 p.

PHARMACOECONOMIC ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY AS THE FIRST LINE OF ADVANCES NON-SQUAMOUS NONSMALL CELL LUNG CANCER TREATMENT

Article

Zyryanov S.K., Frolov M.Yu., Zhuravleva M.V., Rogov V.A., Sakaeva D.D.

Фарматека. Общество с ограниченной ответственностью "Бионика Медиа". 2018. P. 105-114

CLINICAL CASE OF NON-IMMUNE HYDROPS FETALIS CONGENITAL SYPHILIS ATPRETERMINFANT

Article

Shulakova O.A., Karabanov A.M., Zyryanov S.M., Gurevitch K.G.

Неонатология: новости, мнения, обучение. Общество с ограниченной ответственностью Издательская группа ГЭОТАР-Медиа. 2018. P. 83-87

PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY

Article

Bobrova O.P., Dyhno Y.A., Shnayder N.A., Petrova M.M., Zyryanov S.K.

Siberian Journal of Oncology. Tomsk National Research Medical Center of the Russian Academy of Sciences. Vol. 17. 2018. P. 94-100

PHARMACOECONOMIC ANALYSIS OF FLEXIBLE-DOSE ADMINISTRATION REGIMEN OF XEOMINE® IN PATIENTS WITH FOCAL DYSTONIA

Article

Cheberda A.E., Belousov D.Yu., Zyryanov S.K.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 53-65

MODERN MASKS OF INFECTIOUS ENDOCARDITIS

Article

Rodoman G.V., Sumedi I.R., Zyryanov S.K., Ivzhits M.A., Kurmashev A.F., Ionidi P.V., Putsman G.A., Kuchuk A.O.

Antibiotiki i Khimioterapiya. Vol. 63. 2018. P. 18-27

ФАРМАКОЭКОНОМИЧЕСКОЕ ИССЛЕДОВАНИЕ ПРЕПАРАТОВ, ПРИМЕНЯЕМЫХ ПРИ ЛЕЧЕНИИ ПСОРИАЗА СРЕДНЕТЯЖЕЛОЙ И ТЯЖЕЛОЙ СТЕПЕНИ У ПАЦИЕНТОВ С НЕЭФФЕКТИВНОСТЬЮ БАЗОВОЙ СИСТЕМНОЙ ТЕРАПИИ

Article

Зырянов С.К., Чеберда А.Е., Белоусов Д.Ю.

Клиническая фармакология и терапия. Общество с ограниченной ответственностью "Фармапресс". Vol. 27. 2018. P. 91-97

CLINICAL AND ECONOMIC EVALUATION OF USING FIXED DOSE DUAL BRONCHODILATOR COMBINATION TIOTROPIUMOLODATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Article

Zyryanov S.K., Galatonova Y.A.

Медицинский совет. ООО «ГРУППА РЕМЕДИУМ». 2018. P. 61-65

PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD

Article

Zyryanov S.K., D'yakov I.N.

Pulmonologiya. Medical Education. Vol. 28. 2018. P. 61-68

HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2

Article

Ziryanov S.K., Dyakov I.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 4-13

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS

Article

Zyryanov S.K., Cheberda A.E., Belousov D.Y.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 14. 2018. P. 167-175

METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Kardiologiia. KlinMed Consulting. Vol. 58. 2018. P. 82-93

MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION

Article

Zyryanov S.K., Sychyov I.N.

Хирург. 2018. P. 31-43

THERAPY OF BRONCHIAL ASTHMA IN CHILDREN: INHALED CORTICOSTEROIDS VS. ANTAGONISTS OF LEUKOTRIENE RECEPTORS (LITERATURE REVIEW)

Article

Pereverzev A.P., Zyryanov S.K., Ushkalova E.A., Cheltsov V.V.

Consilium Medicum. Общество с ограниченной ответственностью Медицинское маркетинговое агентство МедиаМедика. Vol. 20. 2018. P. 40-44

CLINICO-PHARMACOLOGICAL CHARACTERISTICS OF OPIOID DRUG-DRUG INTERACTIONS IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME

Article

Bobrova O.P., Shnayder N.A., Zyryanov S.K., Dykhno Y.A., Petrova M.M., Nasyrova R.F.

Siberian Journal of Oncology. Tomsk National Research Medical Center of the Russian Academy of Sciences. Vol. 17. 2018. P. 114-122

LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE

Article

ZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.

Antibiotiki i Khimioterapiya. Vol. 63. 2018. P. 46-51

Зырянов С.К.

List of records

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION

GCP INSPECTION BY ROSZDRAVNADZOR

PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA

PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER

THE MONITORING OF DRUG USE SAFETY IN THE MULTISPECIALITY HOSPITAL

IN VITRO EQUIVALENCE EVALUATION OF BETAHISTINE GENERIC MEDICINAL PRODUCTS AS A TOOL POTENTIALLY DETERMINING THE EFFICACY OF PHARMACOTHERAPY [OTSENKA ÉKVIVALENTNOSTI IN VITRO VOSPROIZVEDENNYKH PREPARATOV BETAGISTINA KAK INSTRUMENTA, POTENTSIAL'NO OPREDELIAIUSHCHEGO ÉFFEKTIVNOST' FARMAKOTERAPII]

SELECTION OF MODERN P2Y12 INHIBITOR AS A PART OF DUAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON PRASUGREL

EXTRACELLULAR DNA AND PLASMA NUCLEASE ACTIVITY EFFECT ON THE COURSE OF THE MICROBIAL INFLAMMATORY PROCESS IN THE RESPIRATORY TRACT IN CYSTIC FIBROSIS

PHARMACOEPIDEMIOLOGY OF ANTIBACTERIAL DRUGS FOR PRETERM INFANTS

PHARMACOECONOMIC ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY AS THE FIRST LINE OF ADVANCES NON-SQUAMOUS NONSMALL CELL LUNG CANCER TREATMENT

CLINICAL CASE OF NON-IMMUNE HYDROPS FETALIS CONGENITAL SYPHILIS ATPRETERMINFANT

PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY

PHARMACOECONOMIC ANALYSIS OF FLEXIBLE-DOSE ADMINISTRATION REGIMEN OF XEOMINE® IN PATIENTS WITH FOCAL DYSTONIA

MODERN MASKS OF INFECTIOUS ENDOCARDITIS

CLINICAL AND ECONOMIC EVALUATION OF USING FIXED DOSE DUAL BRONCHODILATOR COMBINATION TIOTROPIUMOLODATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD

HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS

METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT

MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION

THERAPY OF BRONCHIAL ASTHMA IN CHILDREN: INHALED CORTICOSTEROIDS VS. ANTAGONISTS OF LEUKOTRIENE RECEPTORS (LITERATURE REVIEW)

CLINICO-PHARMACOLOGICAL CHARACTERISTICS OF OPIOID DRUG-DRUG INTERACTIONS IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME

LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE

Other authors

Velibekov M.C.

Gorbatenko R.G.